Summary:
COMPANY:​
Takeda Pharmaceutical
INDUSTRIES:​
Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical
HEADQUARTERS:​
Osaka, Osaka, Japan
ABOUT:
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan.
STOCK SYMBOL:
4502: TYO – Tokyo Stock Exchange
IPO STATUS:
Public
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate (marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole (marketed as Prevacid, Ogast, Takepron, and other names), the anti-hypertensive agent candesartan cilexetil (marketed as Blopress, Kenzen, and Amias), and the anti-diabetic agent pioglitazone hydrochloride (marketed as Actos). Segments The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including vitamin bulks, test reagents & clinical diagnostics, photographic chemicals, and inorganic chemicals.
Financials:
FUNDING (USD):​
USD
STATUS:
For Profit
INVESTORS:​
57800000
TOP 5 INVESTORS:​
1
FOUNDERS:​
Chobei Takeda I
LAST LEADERSHIP HIRE:
Bill & Melinda Gates Foundation
EMPLOYEES:
10001+
ACQUISITIONS​:
Bill & Melinda Gates Foundation

Twitter:

Tokyo Office:

2-chōme-1-1 Nihonbashihonchō, Chuo City, Tokyo 103-0023